Glenmark Pharmaceuticals Settles Zetia Case, U.S FDA Closes Inspection At Piramal Pharma's U.S. Unit

Описание: Glenmark Pharmaceuticals has settled a generic drug 'Zetia' case in the United States. On the other hand, The US Food and Drug Administration (USFDA) has concluded its inspection of Piramal Pharma's Sellersville manufacturing facility in the United States, the pharmaceutical firm said on April 19.

Piramal Pharma said the US health regulator issued an Establishment Inspection Report (EIR) for its Sellersville manufacturing facility in Pennsylvania. EIR is the final inspection report of an FDA inspection.

The inspection was conducted between December 19, 2022 and January 13, 2023.

#pharmastocks #glenmarkpharmaceuticals #pirmalpharma #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.

You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Subscribe to our Channel: https://bit.ly/3nvEcxf

Like us on Facebook:   / cnbctv18india  
Follow us on Twitter:   / cnbctv18news  
Follow us on Instagram:   / cnbctv18india  
Catch us on: Linkedin:   / cnbc-tv18  
n18oc_business